68Ga-PSMA-Dual-Contrast PET/MRI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-PSMA-Dual-Contrast PET/MRI, covering 2025-10-31 to 2025-10-31. Get the full timeline:
Most recent: Clinical Trial Update: 68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer [Phase 2]